"Hepatitis B, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Descriptor ID |
D019694
|
| MeSH Number(s) |
C02.256.430.400.100 C02.440.435.100 C06.552.380.350.100 C06.552.380.705.437.100
|
| Concept/Terms |
Hepatitis B, Chronic- Hepatitis B, Chronic
- Chronic Hepatitis B
- Hepatitis B Virus Infection, Chronic
- Chronic Hepatitis B Virus Infection
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B, Chronic".
This graph shows the total number of publications written about "Hepatitis B, Chronic" by people in this website by year, and whether "Hepatitis B, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 0 | 2 |
| 2003 | 3 | 0 | 3 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B, Chronic" by people in Profiles.
-
Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies. Viruses. 2021 06 09; 13(6).
-
Hepatitis B reactivation in patients on biologics: A perfect storm. J Am Acad Dermatol. 2022 01; 86(1):37-38.
-
Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection. Liver Int. 2020 07; 40(7):1693-1700.
-
The immunoglobulin ? marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans. Immunology. 2020 02; 159(2):178-182.
-
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies. Pharmacotherapy. 2019 12; 39(12):1190-1203.
-
Characteristics of amino acid substitutions within the "a" determinant region of hepatitis B virus in chronically infected patients with coexisting HBsAg and anti-HBs. Clin Res Hepatol Gastroenterol. 2020 11; 44(6):923-931.
-
Profile of drug resistance mutations in nucleos(t)ide analogue-experienced chronic hepatitis B patients in Tianjin, China. Int J Antimicrob Agents. 2018 Nov; 52(5):735-736.
-
Liver Fibrosis Reversion After Suppression of Hepatitis B Virus. Clin Liver Dis. 2016 11; 20(4):667-679.
-
Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol. 2013 Nov; 108(11):1723-30.
-
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B. J Hepatol. 2008 May; 48(5):728-35.